FDA Adverse Event Injury Summary report: N

GMK-SPHERE FEMORAL COMPONENT SPHERE TINBN COATED SIZE 5 L

MDR report key: 20133229 · Received September 4, 2024

Report

Report Number
3005180920-2024-00690
Event Type
Injury
Date Received
September 4, 2024
Date of Event
August 5, 2024
Report Date
September 4, 2024
Manufacturer
MEDACTA INTERNATIONAL SA
Product Code
JWH
UDI-DI
07630040711449
PMA / PMN Number
K202684
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

BATCH REVIEW PERFORMED ON 12 AUG 2024. LOT 2304419: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 21-JUN-2023. EXPIRATION DATE: 2028-06-05. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH NO SIMILAR REPORTED EVENT DURING THE PERIOD OF REVIEW. OTHER DEVICES INVOLVED: GMK-SPHERE 02.12.28T3I4L GMK-SPHERE TIBIAL TRAY CEMENTED T3I4L TINBN COATED (K202684) LOT 2300306: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 27-JUN-2023. EXPIRATION DATE: 2028-06-07. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH NO SIMILAR REPORTED EVENT DURING THE PERIOD OF REVIEW. GMK-SPHERE 02.12.E0411FL TIBIAL INSERT FIXED SPHERE FLEX #4/11 MM L E-CROSS (K202022) LOT 2307914: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 19-MAY-2023. EXPIRATION DATE: 2028-04-25. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH NO SIMILAR REPORTED EVENT DURING THE PERIOD OF REVIEW.

Description of Event or Problem · 0

AT ABOUT 2 MONTHS FROM THE PRIMARY, THE PATIENT CAME IN REPORTING ANTERIOR PAIN AND INSTABILITY AND THE CAUSE IS UNKNOWN. THE SURGEON REVISED ALL COMPONENTS WITH REVISION COMPONENTS. THE SURGERY WAS COMPLETED SUCCESSFULLY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1108129 GMK-SPHERE FEMORAL COMPONENT SPHERE TINBN COATED SIZE 5 L KNEE FEMORAL COMPONENT JWH MEDACTA INTERNATIONAL SA 2304419 07630040711449

Patients

Seq Age Sex Outcome Treatment
1 NA Female Required Intervention